Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? (2015)

First Author: Yeung EN
Attributed to:  Nanopatterned Human Liver BioChips for Drug Hepatotoxicity Screening funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12944-015-0069-3

PubMed Identifier: 26256740

Publication URI: http://europepmc.org/abstract/MED/26256740

Type: Journal Article/Review

Volume: 14

Parent Publication: Lipids in health and disease

ISSN: 1476-511X